CEO and President implicated as price-fixing probe widens
November 1, 2017Research and Development, Sales and Marketing Mylan, Teva, biotech, drugs, pharma, pharmaceutical
A group of states, 45 members-strong, has expanded its probe into the generics pharmaceutical industry by expanding its case to …
AstraZeneca asthma therapy tralokinumab flops at Phase 3
November 1, 2017Research and Development AstraZeneca, MedImmune, asthma, pharma
AstraZeneca and MedImmune, the company’s global biologics research and development arm, have announced new Phase 3 data revealing that tralokinumab …
Cancer death rates 61% higher in poorer areas
November 1, 2017Medical Communications, Research and Development NHS, biotech, drugs, pharma, pharmaceutical
Figures released by NHS Scotland have revealed that the numbers of deaths from cancer are 67% higher in the poorest …
Shire to streamline operations with 100-strong plant sale and in-house Cinryze production
October 31, 2017Manufacturing and Production, Sales and Marketing Cinryze, Shire, pharma
Shire has revealed that it plans to sell one of its manufacturing sites in Milford, Massachusetts, having already entered active …
Over-the-counter multinutrient drink could have beneficial impact on Alzheimer’s, new study reveals
October 31, 2017Manufacturing and Production, Research and Development Alzheimer's, Fortasyn Connect, Souvenaid, dementia
LipiDiDiet, a European project investigating “the impact of nutritional lipids on neuronal and cognitive performance in ageing, Alzheimer’s disease and …
Novartis submits second FDA application for CAR-T therapy Kymriah, this time in diffuse large B-cell lymphoma
October 31, 2017Manufacturing and Production, Sales and Marketing CAR-T, Kymriah, Novartis
Following the “historic” FDA approval of the company’s CAR-T therapy Kymriah (tisagenlecleucel) in the treatment of paediatric and young adults …
Kirin Holdings to withdraw from 30 year venture with Amgen, sell shares for $780m
October 31, 2017Manufacturing and Production, Research and Development, Sales and Marketing Amgen, Kirin, joint venture, pharma
Japanese firm Kirin Holdings has announced its intention to withdraw from a joint research collaboration with Amgen, saying it would …
Janssen’s Stelara shows improvement in Crohn’s symptoms within one week, new findings reveal
October 30, 2017Manufacturing and Production, Research and Development Crohn’s disease, Janssen, Stelara, crohn's disease, pharma
Janssen has unveiled new data on Stelara (ustekinumab) in the treatment of patients with moderately to severely active Crohn’s disease …
MSD withdraws European application of Keytruda combo in lung cancer
October 30, 2017Sales and Marketing EMA, MSD, keytruda
MSD has been forced to withdraw its EU marketing application for Keytruda (pembrolizumab) in combination with pemetrexed and carboplatin as …
AstraZeneca licenses genetic disease drug to Mereo Biopharma for $5 million, becomes shareholder
October 30, 2017Sales and Marketing AstraZeneca, Mereo BioPharma, pharma
AstraZeneca has agreed to license AZD9668, its experimental drug for the treatment of alpha-1 antitrypsin deficiency, to Mereo Biopharma for …
Novartis to bolster oncology portfolio with $3.9 billion acquisition
October 30, 2017Sales and Marketing Advanced Acclerator Applications, Lutathera, Novartis, pharma
Novartis has announced its intention to acquire France’s Advanced Accelerator Applications (AAA) for $3.9 billion in a move to reinforce …
Samsung Biologics reinforces biologic manufacturing and development partnership with MSD
October 30, 2017Manufacturing and Production, Sales and Marketing Korea, MSD, Samsung BioLogics, pharma
Samsung Biologics has announced it has expanded its strategic alliance with MSD, or Merck as it is known in the …
Switching Crohn’s patients to biosimilar Inflectra from Remicade is safe and effective, Pfizer says
October 30, 2017Research and Development, Sales and Marketing Crohn’s disease, Pfizer, Remicade, crohn's disease, inflectra, pharma
Pfizer has released new data on its Crohn’s disease (CD) treatment Inflectra (infliximab CT-P13) which indicate that switching patients to …
Collaboration in Biopharma
October 27, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical
Dear Colleague,
Top Ten most popular articles on Pharmafile.com this week
October 27, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten
October is almost over and Halloween is just around the corner, and it’s time for another run-down of the stories …
NHS was crippled by “unsophisticated” cyber attack
October 27, 2017Medical Communications NHS, biotech, drugs, pharma, pharmaceutical
Back in May of this year, the NHS was hit by a cyber attack that severely impacted at least 34% …
Insys Pharma founder charged over “nationwide conspiracy” to illegally distribute fentanyl
October 27, 2017Medical Communications, Sales and Marketing Insys Pharma, Subsys, fentanyl, opioid crisis, opioids
John N Kapoor, the 74-year old founder of Insys Pharma, has been legally charged over his involvement in driving a …
Celgene hikes price of Revlimid to mask poor Q3 results
October 27, 2017Medical Communications, Sales and Marketing Celgene, Revlimid, biotech, drugs, pharma, pharmaceutical
Celgene posted its Q3 results and investors did not react well – shares plunged 16% immediately, after the biotech cut …
AbbVie’s psoriasis drug smashes all endpoints
October 26, 2017Medical Communications, Research and Development AbbVie, IL-23, biotech, drugs, pharma, pharmaceutical, risankizumab
AbbVie already know well what it’s like to have a lead candidate in the psoriasis field, after having Humira sat …
Is the NHS prepared for the upcoming winter season?
October 26, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Insider Interview, Interview, NHS, pharma
After the health service struggled through the same period last year, Amber Jabbal, Head of Policy at NHS Providers sets …
Latest content
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion
